Ballachanda Subbaiah Taaran Cariappa, Feldman Jeremy P
St. Joseph's Hospital and Medical Center, USA.
Arizona Pulmonary Specialists, USA.
Respir Med Case Rep. 2017 May 9;21:164-166. doi: 10.1016/j.rmcr.2017.05.001. eCollection 2017.
We present a 51 year old, African American, female who presented with persistent hypoxemia. She had been taking dapsone for many years for prophylaxis against Pneumocystic Jiroveci with no symptoms but eventually developed methemoglobinemia only after a splenectomy. From our literature review there are no documented cases that have demonstrated this relationship between dapsone, splenic function and methemoglobin and we hope to share our perplexing case and shed light on the interaction.
Our patient has type 1 diabetes and underwent multiple pancreas transplants and an initial kidney transplant during her disease course. One year prior to her presentation she underwent a distal pancreatectomy and an incidental splenectomy during the same procedure. She had been taking dapsone for approximately 17 years due to her allergy to sulfamethoxazole/trimethoprim and her immunosuppressive regimen included tacrolimus, sirolimus, and low dose prednisone. She had presented for a routine, post-surgery follow up visit when she was diagnosed with hypoxemia. After an extensive but unsuccessful work up for persistent hypoxemia, she presented to our clinic for a second opinion. Repeat testing of the arterial blood gas in clinic showed a significant methemoglobin (MHb) level of 16.6 mg/dl.
Although methemoglobinemia is a well-known risk of dapsone exposure, we report a case that suggests that splenectomy can interact with dapsone to further increase the risk of methemobloginemia. We believe that our patient did not develop methemoglobinemia initially, despite being on dapsone for many years because her spleen was able to remove older more susceptible erythrocytes from the circulation leaving the more robust younger erythrocytes. With the splenectomy, the number of older erythrocytes in the peripheral circulation increased and resulted in an accumulation of MHb leading to the low oxygen saturations. Her dapsone was immediately stopped and she was started on vitamin C with a 3 day follow up revealing resolution of her methemoglobinemia and normal oxygen saturation on room air.
我们报告一位51岁的非裔美国女性,她患有持续性低氧血症。她多年来一直服用氨苯砜预防耶氏肺孢子菌感染,此前并无症状,但在脾切除术后最终出现了高铁血红蛋白血症。通过文献回顾,我们未发现有记录表明氨苯砜、脾脏功能与高铁血红蛋白之间存在这种关系,我们希望分享这一令人困惑的病例,并阐明它们之间的相互作用。
我们的患者患有1型糖尿病,在病程中接受了多次胰腺移植和一次肾脏移植。在就诊前一年,她在同一次手术中接受了远端胰腺切除术和意外的脾切除术。由于对磺胺甲恶唑/甲氧苄啶过敏,她服用氨苯砜约17年,免疫抑制方案包括他克莫司、西罗莫司和低剂量泼尼松。她在术后常规随访时被诊断为低氧血症。在对持续性低氧血症进行了广泛但未成功的检查后,她到我们诊所寻求第二种意见。在诊所重复检测动脉血气显示高铁血红蛋白(MHb)水平显著升高,达到16.6mg/dl。
虽然高铁血红蛋白血症是已知的氨苯砜暴露风险,但我们报告的这个病例表明,脾切除术可能与氨苯砜相互作用,进一步增加高铁血红蛋白血症的风险。我们认为,尽管我们的患者多年来一直服用氨苯砜,但最初并未出现高铁血红蛋白血症,因为她的脾脏能够从循环中清除较老、更易受影响的红细胞,留下更健壮的年轻红细胞。脾切除术后,外周循环中较老红细胞的数量增加,导致高铁血红蛋白积聚,从而导致氧饱和度降低。立即停用她的氨苯砜,并开始使用维生素C,3天的随访显示她的高铁血红蛋白血症得到缓解,在室内空气中氧饱和度恢复正常。